Merit Medical Systems Inc (MMSI) - Multiplikator forward rega marang pendapatan
Merit Medical Systems (MMSI) products for oncology and cardiology demonstrate steady long-term growth. The projected P/S dynamics confirm this trend, with the current level sitting around 1.90. Business stability is based on B2B supplies of disposable radiology instruments. The company's innovative sensors and catheters minimize surgical trauma, transforming engineering developments into effective life-saving methods.
Merit Medical Corp - rincian analitis lan metrik utama (MMSI)
- rega pasar lan target rega analis:
- indikator kapitalisasi pasar:
- rincian valuasi buku bisnis:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Merit Medical Systems|MMSI - Rasio utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Merit Medical Systems|MMSI - Tanggungan utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Merit Medical Systems|MMSI - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Merit Medical|Rasio cepet merit.com
- data bathi bisnis lan rasio investasi:
MMSI - Penghasilan resik perusahaan|Bathi sing dikarepake Merit Medical Systems|MMSI - Nilai perusahaan marang bathi resik|Pangali Forward P/E Merit Medical Systems Inc|MMSI - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Merit Medical Systems|MMSI - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Merit Medical|MMSI - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan merit.com|MMSI - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Merit Medical Systems
- data dodolan lan asil:
Analisis umum perusahaan:MMSI (Merit Medical)
The forward P/S reflects the market value of Merit Medical Systems (MMSI) relative to expected revenue, allowing investors to assess the extent of the premium or discount for future cash flows. Analyzing the forward P/S trend on the GURU.Markets platform reveals how strong patent protection and the deep integration of Merit Medical Systems (MMSI) devices into hospital practice ensure valuation stability even amidst fluctuations in consensus forecasts.
Analisis perusahaan pesaing
Rasio rega marang prakiraan pendapatan Intuitive ISRG|Rega forward marang dodolan DHR|BDX: Multiplikator forward rega marang pendapatan|STE - Multiplikator Forward P/S|West Pharmaceutical Services (WST) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan baxter.com|MASI (Masimo) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Stevanato Group SpA STVN|Rasio rega marang prakiraan pendapatan Teleflex Inc (TFX)|Nobel Biocare - Kapitalisasi marang prakiraan pendapatan|ICU Medical, Inc. - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake XRAY (dentsplysirona.com)|LMAT - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake AtriCure Inc ATRC|STAAR Surgical Corp (STAA) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Niagen|ZIMV (ZimVie Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep angiodynamics.com ANGO|Rasio rega marang prakiraan pendapatan Cerus (CERS)|TKNO (Alpha Teknova) - Rega forward marang dodolan|Multiplikator Forward P/S MGRM (Monogram Technologies Inc)|Rasio kapitalisasi marang dodolan sing dikarepake Sharps Technology Inc (STSS)|INFU: Multiplikator forward rega marang pendapatan|utahmed.com - Rasio rega marang pendapatan sing dikarepake|KRMD (korumedical.com) - Multiplikator forward rega marang pendapatan|Nyxoah SA - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Microbot Medical Inc|Multiplikator forward rega marang pendapatan Pro-Dex Inc. (PDEX)|Multiplikator Forward P/S ZTEK|ELUT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S MLSS (Milestone Scientific Inc.)|NXGL: Kapitalisasi marang prakiraan pendapatan|Retractable Tech - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake harvardbioscience.com HBIO|FEMY: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Meihua Medical Technologies Co., Ltd.|POAI (Predictive Oncology Inc) - Multiplikator Forward P/S|Multiplikator Forward P/S Callan JMB Corp|Rasio rega marang prakiraan pendapatan Atrion Corp (ATRI)|Rasio rega marang prakiraan pendapatan NURO (NeuroMetrix Corporation)
